Urology Market Analysis, Size, Trends | Brazil | 2020-2026 | MedSuite (Includes 6 Reports)

iData Research
407 Pages - IDR10541
$8,995.00

BPH is prevalent among men over the age of 50 years. Prevalence increases with age, reaching
figures of 85% to 90% for men above the age of 80. Brazil is aging at record highs. By 2050, Brazil
will have around 66 million people above the age 60 living in its territory, or three times more than the 24 million today

'

TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XIX
EXECUTIVE SUMMARY 1
BRAZIL UROLOGICAL DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 7
PROCEDURE NUMBERS 8
MARKETS INCLUDED 9
VERSION HISTORY 10
RESEARCH METHODOLOGY 11
Step 1: Project Initiation & Team Selection 11
Step 2: Prepare Data Systems and Perform Secondary Research 14
Step 3: Preparation for Interviews & Questionnaire Design 16
Step 4: Performing Primary Research 17
Step 5: Research Analysis: Establishing Baseline Estimates 19
Step 6: Market Forecast and Analysis 20
Step 7: Identify Strategic Opportunities 22
Step 8: Final Review and Market Release 23
Step 9: Customer Feedback and Market Monitoring 24
DISEASE OVERVIEW 25
2.1 BASIC ANATOMY 25
2.1.1 Urinary System 25
2.1.1.1 Male Urinary System 26
2.1.1.2 Female Urinary System 27
2.2 DISEASE TREATMENT AND DIAGNOSTICS 28
2.2.1 Benign Prostatic Hyperplasia 28
2.2.2 Urinary Incontinence 30
2.2.3 Urinary Tract Infections 32
2.2.4 Kidney Stones 33
2.2.5 Bladder Prolapse 35
2.2.6 Overactive Bladder 36
2.2.7 Prostatitis 37
2.2.8 Erectile Dysfunction 39
2.2.9 Cancer 41
2.2.9.1 Prostate Cancer 41
2.2.9.2 Bladder Cancer 42
2.2.10 Indications for Pelvic Organ Prolapse Repair 43
PRODUCT ASSESSMENT 45
3.1 INTRODUCTION 45
3.2 PRODUCT PORTFOLIOS 45
3.2.1 Urinary Incontinence 45
3.2.1.1 Urinary Catheters 45
3.2.1.1.1 Intermittent Catheters 45
3.2.1.1.2 Foley Catheters 46
3.2.1.1.3 Male External Catheters 47
3.2.1.2 Urethral Bulking Agents 48
3.2.1.3 Incontinence Management Devices 49
3.2.1.3.1 Female Incontinence Slings 49
3.2.1.3.2 Male Implantable Devices 50
3.2.1.4 Urine Bags 52
3.2.1.4.1 Leg Bags 52
3.2.1.4.2 Night Bags 52
3.2.2 Pelvic Organ Prolapse Repair 57
3.2.2.1 Autologous Tissue as an Alternative to Vaginal Mesh 58
3.2.2.2 Product Matrix for Pelvic Organ Prolapse Repair 59
3.2.3 Stone Management 60
3.2.3.1 ESWL Equipment 60
3.2.3.2 ISWL Equipment 61
3.2.3.3 Holmium Lasers 61
3.2.3.4 Stone Fragment Retrieval Devices 62
3.2.3.5 Ureteral Stents 62
3.2.4 BPH Treatment 66
3.2.4.1 TURP 66
3.2.4.2 TUMT 67
3.2.4.3 TUNA 67
3.2.4.4 Prostatic Stents 68
3.2.4.5 Laser BPH 69
3.2.4.5.1 Photoselective Vaporization of the Prostate (PVP) 70
3.2.4.5.2 Laser Vaporization of the Prostate 71
3.2.4.5.3 Laser Ablation of the Prostate 72
3.2.4.5.4 Laser Resection of the Prostate 72
3.2.4.5.5 Laser Enucleation of the Prostate 73
3.2.5 Erectile Dysfunction 75
3.2.5.1 Penile Implants 75
3.2.5.1.1 Inflatable 75
3.2.5.1.2 Malleable 76
3.2.5.2 Vacuum 76
3.3 REGULATORY ISSUES AND RECALLS 78
3.3.1 Boston Scientific 78
3.3.1.1 Stone Management 78
3.3.1.2 Nephrostomy 80
3.3.2 C. R. Bard (Becton Dickinson) 81
3.3.2.1 Urinary Incontinence 81
3.3.2.2 Stone Management 86
3.3.2.3 Urological Endoscopes 86
3.3.2.4 Prostate Cancer Treatment 86
3.3.2.5 Nephrostomy 87
3.3.3 Coloplast 89
3.3.3.1 Urinary Catheter 89
3.3.3.2 Erectile Dysfunction 89
3.3.4 Cook Medical 90
3.3.4.1 Stone Management 90
3.3.4.2 Nephrostomy 91
3.3.5 Elekta 93
3.3.5.1 Prostate Cancer Treatment 93
3.3.6 Karl Storz 94
3.3.6.1 Urological Endoscopes 94
3.3.7 Olympus 95
3.3.7.1 Urological Endoscopes 95
3.4 CLINICAL TRIALS 97
3.4.1 Boston Scientific 97
3.4.1.1 Urinary Incontinence 97
3.4.1.2 BPH Treatment 98
3.4.1.3 Urological endoscopes 99
3.4.1.4 Nephrostomy 100
3.4.1.5 Erectile Dysfunction 101
3.4.2 C. R. Bard (Becton Dickinson) 102
3.4.2.1 Urinary Incontinence 102
3.4.2.2 Prostate Cancer Treatment 104
3.4.3 Coloplast 105
3.4.3.1 Urinary Incontinence 105
3.4.4 Cook Medical 108
3.4.4.1 Nephrostomy 108
3.4.5 Elekta 110
3.4.5.1 Prostate Cancer Treatment 110
3.4.6 Ethicon (Johnson & Johnson) 112
3.4.6.1 Urinary Incontinence 112
3.4.7 Karl Storz 114
3.4.7.1 Stone Management 114
3.4.7.2 Urological Endoscopes 116
3.4.8 Laborie 119
3.4.8.1 Urodynamics 119
3.4.9 Medline 121
3.4.9.1 Urinary Incontinence 121
3.4.10 Olympus 122
3.4.10.1 Stone Management 122
3.4.10.2 BPH Treatment 123
3.4.10.3 Urological Endoscopes 124
BRAZIL UROLOGICAL DEVICE MARKET OVERVIEW 126
4.1 INTRODUCTION 126
4.2 CURRENCY EXCHANGE RATE 127
4.3 MARKET OVERVIEW 128
4.4 TREND ANALYSIS BY SEGMENT 134
4.5 DRIVERS AND LIMITERS 138
4.5.1 Market Drivers 138
4.5.2 Market Limiters 139
4.6 COMPETITIVE MARKET SHARE ANALYSIS 141
4.7 MERGERS AND ACQUISITIONS 148
4.8 COMPANY PROFILES 150
4.8.1 Boston Scientific 150
4.8.2 C. R. Bard (Becton Dickinson) 152
4.8.3 Coloplast 154
4.8.4 Cook Medical 155
4.8.5 Ethicon (Johnson & Johnson) 156
4.8.6 Karl Storz 157
4.8.7 Laborie 158
4.8.8 Olympus 159
4.9 SWOT ANALYSIS 161
4.9.1 Boston Scientific 162
4.9.2 C. R. Bard (Becton Dickinson) 164
4.9.3 Coloplast 166
4.9.4 Cook Medical 167
4.9.5 Ethicon (Johnson & Johnson) 169
4.9.6 Karl Storz 170
4.9.7 Laborie 171
4.9.8 Olympus 172
PROCEDURE NUMBERS 174
5.1 PROCEDURE OVERVIEW 174
5.2 URINARY INCONTINENCE PROCEDURES 179
5.2.1 Male Incontinence Management Procedures 181
5.2.2 Female Incontinence Management Procedures 184
5.3 PELVIC ORGAN PROLAPSE REPAIR PROCEDURES 187
5.4 STONE MANAGEMENT PROCEDURES 189
5.4.1 ESWL Procedures 191
5.4.2 Transurethral Procedures 193
5.4.3 Ureteral Stent Placement Procedures 195
5.4.4 PCNL Procedures 197
5.5 BPH PROCEDURES 199
5.6 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 201
URINARY INCONTINENCE MANAGEMENT DEVICE MARKET 204
6.1 INTRODUCTION 204
6.2 MARKET OVERVIEW 206
6.3 MARKET ANALYSIS AND FORECAST 211
6.3.1 Total Urinary Catheter Market 211
6.3.1.1 Intermittent Catheter Market 214
6.3.1.2 Foley Catheter Market 216
6.3.1.3 Male External Catheter Market 218
6.3.2 Total Urethral Bulking Agent Market 220
6.3.2.1 Male Urethral Bulking Agent Market 224
6.3.2.2 Female Urethral Bulking Agent Market 226
6.3.3 Total Incontinence Management Device Market 228
6.3.3.1 Total Male Implantable Incontinence Device Market 231
6.3.3.1.1 Male Incontinence Sling Market 236
6.3.3.1.2 Male Artificial Urinary Sphincter Market 238
6.3.3.2 Total Female Incontinence Sling Market 240
6.3.3.2.1 Transvaginal Tape Female Incontinence Sling Market 245
6.3.3.2.2 Transobturator Female Incontinence Sling Market 247
6.3.3.2.3 Single-Incision Female Incontinence Sling Market 249
6.4 DRIVERS AND LIMITERS 251
6.4.1 Market Drivers 251
6.4.2 Market Limiters 252
6.5 COMPETITIVE MARKET SHARE ANALYSIS 255
PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET 260
7.1 INTRODUCTION 260
7.2 MARKET OVERVIEW 262
7.3 MARKET ANALYSIS AND FORECAST 267
7.3.1 Total Pelvic Organ Prolapse Repair Device Market 267
7.3.2 Transvaginal Mesh Market 270
7.3.3 Sacrocolpopexy Mesh Market 273
7.4 DRIVERS AND LIMITERS 275
7.4.1 Market Drivers 275
7.4.2 Market Limiters 276
7.5 COMPETITIVE MARKET SHARE ANALYSIS 278

STONE MANAGEMENT DEVICE MARKET 281
8.1 INTRODUCTION 281
8.2 MARKET OVERVIEW 283
8.3 MARKET ANALYSIS AND FORECAST 289
8.3.1 ESWL Equipment Market 289
8.3.2 ISWL Equipment Market 292
8.3.3 Total Holmium Laser Market 295
8.3.3.1 Holmium Laser Equipment Market 298
8.3.3.2 Holmium Laser Fiber Market 300
8.3.4 Total Stone Fragment Retrieval Device Market 303
8.3.4.1 Nitinol Stone Fragment Retrieval Device Market 309
8.3.4.2 Stainless Steel Stone Fragment Retrieval Device Market 311
8.3.5 Ureteral Stent Market 313
8.3.6 Ureteral Guidewire Market 316
8.4 DRIVERS AND LIMITERS 319
8.4.1 Market Drivers 319
8.4.2 Market Limiters 320
8.5 COMPETITIVE MARKET SHARE ANALYSIS 323
BPH TREATMENT DEVICE MARKET 329
9.1 INTRODUCTION 329
9.1.1 Treatments 329
9.1.1.1 TURP 330
9.1.1.2 Minimally Invasive Treatments 330
9.1.1.3 Laser BPH Treatments 331
9.1.2 Comparison of TURP and Laser BPH Procedures 331
9.1.3 Emerging Technologies 332
9.2 MARKET OVERVIEW 334
9.3 MARKET ANALYSIS AND FORECAST 339
9.3.1 Total TURP Market 339
9.3.1.1 Monopolar Electrode Market 342
9.3.1.2 Bipolar Electrode Market 344
9.3.2 Total Laser BPH Market 346
9.3.2.1 Laser BPH Equipment Market 349
9.3.2.2 Laser BPH Fiber Market 351
9.4 DRIVERS AND LIMITERS 353
9.4.1 Market Limiters 355
9.5 COMPETITIVE MARKET SHARE ANALYSIS 358
ERECTILE DYSFUNCTION DEVICE MARKET 362
10.1 INTRODUCTION 362
10.1.1 Low Testosterone Pharmaceutical Delivery 363
10.2 MARKET OVERVIEW 364
10.3 MARKET ANALYSIS AND FORECAST 370
10.3.1 Inflatable Erectile Dysfunction Device Market 370
10.3.2 Malleable Erectile Dysfunction Device Market 373
10.4 DRIVERS AND LIMITERS 375
10.4.1 Market Drivers 375
10.4.2 Market Limiters 376
10.5 COMPETITIVE MARKET SHARE ANALYSIS 378
ABBREVIATIONS 382
TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XIX
EXECUTIVE SUMMARY 1
BRAZIL UROLOGICAL DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 7
PROCEDURE NUMBERS 8
MARKETS INCLUDED 9
VERSION HISTORY 10
RESEARCH METHODOLOGY 11
Step 1: Project Initiation & Team Selection 11
Step 2: Prepare Data Systems and Perform Secondary Research 14
Step 3: Preparation for Interviews & Questionnaire Design 16
Step 4: Performing Primary Research 17
Step 5: Research Analysis: Establishing Baseline Estimates 19
Step 6: Market Forecast and Analysis 20
Step 7: Identify Strategic Opportunities 22
Step 8: Final Review and Market Release 23
Step 9: Customer Feedback and Market Monitoring 24
DISEASE OVERVIEW 25
2.1 BASIC ANATOMY 25
2.1.1 Urinary System 25
2.1.1.1 Male Urinary System 26
2.1.1.2 Female Urinary System 27
2.2 DISEASE TREATMENT AND DIAGNOSTICS 28
2.2.1 Benign Prostatic Hyperplasia 28
2.2.2 Urinary Incontinence 30
2.2.3 Urinary Tract Infections 32
2.2.4 Kidney Stones 33
2.2.5 Bladder Prolapse 35
2.2.6 Overactive Bladder 36
2.2.7 Prostatitis 37
2.2.8 Erectile Dysfunction 39
2.2.9 Cancer 41
2.2.9.1 Prostate Cancer 41
2.2.9.2 Bladder Cancer 42
2.2.10 Indications for Pelvic Organ Prolapse Repair 43
PRODUCT ASSESSMENT 45
3.1 INTRODUCTION 45
3.2 PRODUCT PORTFOLIOS 45
3.2.1 Urinary Incontinence 45
3.2.1.1 Urinary Catheters 45
3.2.1.1.1 Intermittent Catheters 45
3.2.1.1.2 Foley Catheters 46
3.2.1.1.3 Male External Catheters 47
3.2.1.2 Urethral Bulking Agents 48
3.2.1.3 Incontinence Management Devices 49
3.2.1.3.1 Female Incontinence Slings 49
3.2.1.3.2 Male Implantable Devices 50
3.2.1.4 Urine Bags 52
3.2.1.4.1 Leg Bags 52
3.2.1.4.2 Night Bags 52
3.2.2 Pelvic Organ Prolapse Repair 57
3.2.2.1 Autologous Tissue as an Alternative to Vaginal Mesh 58
3.2.2.2 Product Matrix for Pelvic Organ Prolapse Repair 59
3.2.3 Stone Management 60
3.2.3.1 ESWL Equipment 60
3.2.3.2 ISWL Equipment 61
3.2.3.3 Holmium Lasers 61
3.2.3.4 Stone Fragment Retrieval Devices 62
3.2.3.5 Ureteral Stents 62
3.2.4 BPH Treatment 66
3.2.4.1 TURP 66
3.2.4.2 TUMT 67
3.2.4.3 TUNA 67
3.2.4.4 Prostatic Stents 68
3.2.4.5 Laser BPH 69
3.2.4.5.1 Photoselective Vaporization of the Prostate (PVP) 70
3.2.4.5.2 Laser Vaporization of the Prostate 71
3.2.4.5.3 Laser Ablation of the Prostate 72
3.2.4.5.4 Laser Resection of the Prostate 72
3.2.4.5.5 Laser Enucleation of the Prostate 73
3.2.5 Erectile Dysfunction 75
3.2.5.1 Penile Implants 75
3.2.5.1.1 Inflatable 75
3.2.5.1.2 Malleable 76
3.2.5.2 Vacuum 76
3.3 REGULATORY ISSUES AND RECALLS 78
3.3.1 Boston Scientific 78
3.3.1.1 Stone Management 78
3.3.1.2 Nephrostomy 80
3.3.2 C. R. Bard (Becton Dickinson) 81
3.3.2.1 Urinary Incontinence 81
3.3.2.2 Stone Management 86
3.3.2.3 Urological Endoscopes 86
3.3.2.4 Prostate Cancer Treatment 86
3.3.2.5 Nephrostomy 87
3.3.3 Coloplast 89
3.3.3.1 Urinary Catheter 89
3.3.3.2 Erectile Dysfunction 89
3.3.4 Cook Medical 90
3.3.4.1 Stone Management 90
3.3.4.2 Nephrostomy 91
3.3.5 Elekta 93
3.3.5.1 Prostate Cancer Treatment 93
3.3.6 Karl Storz 94
3.3.6.1 Urological Endoscopes 94
3.3.7 Olympus 95
3.3.7.1 Urological Endoscopes 95
3.4 CLINICAL TRIALS 97
3.4.1 Boston Scientific 97
3.4.1.1 Urinary Incontinence 97
3.4.1.2 BPH Treatment 98
3.4.1.3 Urological endoscopes 99
3.4.1.4 Nephrostomy 100
3.4.1.5 Erectile Dysfunction 101
3.4.2 C. R. Bard (Becton Dickinson) 102
3.4.2.1 Urinary Incontinence 102
3.4.2.2 Prostate Cancer Treatment 104
3.4.3 Coloplast 105
3.4.3.1 Urinary Incontinence 105
3.4.4 Cook Medical 108
3.4.4.1 Nephrostomy 108
3.4.5 Elekta 110
3.4.5.1 Prostate Cancer Treatment 110
3.4.6 Ethicon (Johnson & Johnson) 112
3.4.6.1 Urinary Incontinence 112
3.4.7 Karl Storz 114
3.4.7.1 Stone Management 114
3.4.7.2 Urological Endoscopes 116
3.4.8 Laborie 119
3.4.8.1 Urodynamics 119
3.4.9 Medline 121
3.4.9.1 Urinary Incontinence 121
3.4.10 Olympus 122
3.4.10.1 Stone Management 122
3.4.10.2 BPH Treatment 123
3.4.10.3 Urological Endoscopes 124
BRAZIL UROLOGICAL DEVICE MARKET OVERVIEW 126
4.1 INTRODUCTION 126
4.2 CURRENCY EXCHANGE RATE 127
4.3 MARKET OVERVIEW 128
4.4 TREND ANALYSIS BY SEGMENT 134
4.5 DRIVERS AND LIMITERS 138
4.5.1 Market Drivers 138
4.5.2 Market Limiters 139
4.6 COMPETITIVE MARKET SHARE ANALYSIS 141
4.7 MERGERS AND ACQUISITIONS 148
4.8 COMPANY PROFILES 150
4.8.1 Boston Scientific 150
4.8.2 C. R. Bard (Becton Dickinson) 152
4.8.3 Coloplast 154
4.8.4 Cook Medical 155
4.8.5 Ethicon (Johnson & Johnson) 156
4.8.6 Karl Storz 157
4.8.7 Laborie 158
4.8.8 Olympus 159
4.9 SWOT ANALYSIS 161
4.9.1 Boston Scientific 162
4.9.2 C. R. Bard (Becton Dickinson) 164
4.9.3 Coloplast 166
4.9.4 Cook Medical 167
4.9.5 Ethicon (Johnson & Johnson) 169
4.9.6 Karl Storz 170
4.9.7 Laborie 171
4.9.8 Olympus 172
PROCEDURE NUMBERS 174
5.1 PROCEDURE OVERVIEW 174
5.2 URINARY INCONTINENCE PROCEDURES 179
5.2.1 Male Incontinence Management Procedures 181
5.2.2 Female Incontinence Management Procedures 184
5.3 PELVIC ORGAN PROLAPSE REPAIR PROCEDURES 187
5.4 STONE MANAGEMENT PROCEDURES 189
5.4.1 ESWL Procedures 191
5.4.2 Transurethral Procedures 193
5.4.3 Ureteral Stent Placement Procedures 195
5.4.4 PCNL Procedures 197
5.5 BPH PROCEDURES 199
5.6 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 201
URINARY INCONTINENCE MANAGEMENT DEVICE MARKET 204
6.1 INTRODUCTION 204
6.2 MARKET OVERVIEW 206
6.3 MARKET ANALYSIS AND FORECAST 211
6.3.1 Total Urinary Catheter Market 211
6.3.1.1 Intermittent Catheter Market 214
6.3.1.2 Foley Catheter Market 216
6.3.1.3 Male External Catheter Market 218
6.3.2 Total Urethral Bulking Agent Market 220
6.3.2.1 Male Urethral Bulking Agent Market 224
6.3.2.2 Female Urethral Bulking Agent Market 226
6.3.3 Total Incontinence Management Device Market 228
6.3.3.1 Total Male Implantable Incontinence Device Market 231
6.3.3.1.1 Male Incontinence Sling Market 236
6.3.3.1.2 Male Artificial Urinary Sphincter Market 238
6.3.3.2 Total Female Incontinence Sling Market 240
6.3.3.2.1 Transvaginal Tape Female Incontinence Sling Market 245
6.3.3.2.2 Transobturator Female Incontinence Sling Market 247
6.3.3.2.3 Single-Incision Female Incontinence Sling Market 249
6.4 DRIVERS AND LIMITERS 251
6.4.1 Market Drivers 251
6.4.2 Market Limiters 252
6.5 COMPETITIVE MARKET SHARE ANALYSIS 255
PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET 260
7.1 INTRODUCTION 260
7.2 MARKET OVERVIEW 262
7.3 MARKET ANALYSIS AND FORECAST 267
7.3.1 Total Pelvic Organ Prolapse Repair Device Market 267
7.3.2 Transvaginal Mesh Market 270
7.3.3 Sacrocolpopexy Mesh Market 273
7.4 DRIVERS AND LIMITERS 275
7.4.1 Market Drivers 275
7.4.2 Market Limiters 276
7.5 COMPETITIVE MARKET SHARE ANALYSIS 278

STONE MANAGEMENT DEVICE MARKET 281
8.1 INTRODUCTION 281
8.2 MARKET OVERVIEW 283
8.3 MARKET ANALYSIS AND FORECAST 289
8.3.1 ESWL Equipment Market 289
8.3.2 ISWL Equipment Market 292
8.3.3 Total Holmium Laser Market 295
8.3.3.1 Holmium Laser Equipment Market 298
8.3.3.2 Holmium Laser Fiber Market 300
8.3.4 Total Stone Fragment Retrieval Device Market 303
8.3.4.1 Nitinol Stone Fragment Retrieval Device Market 309
8.3.4.2 Stainless Steel Stone Fragment Retrieval Device Market 311
8.3.5 Ureteral Stent Market 313
8.3.6 Ureteral Guidewire Market 316
8.4 DRIVERS AND LIMITERS 319
8.4.1 Market Drivers 319
8.4.2 Market Limiters 320
8.5 COMPETITIVE MARKET SHARE ANALYSIS 323
BPH TREATMENT DEVICE MARKET 329
9.1 INTRODUCTION 329
9.1.1 Treatments 329
9.1.1.1 TURP 330
9.1.1.2 Minimally Invasive Treatments 330
9.1.1.3 Laser BPH Treatments 331
9.1.2 Comparison of TURP and Laser BPH Procedures 331
9.1.3 Emerging Technologies 332
9.2 MARKET OVERVIEW 334
9.3 MARKET ANALYSIS AND FORECAST 339
9.3.1 Total TURP Market 339
9.3.1.1 Monopolar Electrode Market 342
9.3.1.2 Bipolar Electrode Market 344
9.3.2 Total Laser BPH Market 346
9.3.2.1 Laser BPH Equipment Market 349
9.3.2.2 Laser BPH Fiber Market 351
9.4 DRIVERS AND LIMITERS 353
9.4.1 Market Limiters 355
9.5 COMPETITIVE MARKET SHARE ANALYSIS 358
ERECTILE DYSFUNCTION DEVICE MARKET 362
10.1 INTRODUCTION 362
10.1.1 Low Testosterone Pharmaceutical Delivery 363
10.2 MARKET OVERVIEW 364
10.3 MARKET ANALYSIS AND FORECAST 370
10.3.1 Inflatable Erectile Dysfunction Device Market 370
10.3.2 Malleable Erectile Dysfunction Device Market 373
10.4 DRIVERS AND LIMITERS 375
10.4.1 Market Drivers 375
10.4.2 Market Limiters 376
10.5 COMPETITIVE MARKET SHARE ANALYSIS 378
ABBREVIATIONS 382

Figure 1 1: Urological Device Market Share Ranking by Segment, Brazil, 2019 4
Figure 1 2: Companies Researched in this Report, Brazil 5
Figure 1 3: Factors Impacting the Urological Device Market by Segment, Brazil 6
Figure 1 4: Recent Events in the Urological Device Market, 2018 – 2019 7
Figure 1 5: Urological Procedures Covered, Brazil 8
Figure 1 6: Urological Device Markets Covered, Brazil (1 of 2) 9
Figure 1 7: Urological Device Markets Covered, Brazil (2 of 2) 10
Figure 1 8: Version History 10
Figure 3 1: Urinary Incontinence Treatments by Company (1 of 3) 54
Figure 3 2: Urinary Incontinence Treatments by Company (2 of 3) 55
Figure 3 3: Urinary Incontinence Treatments by Company (3 of 3) 56
Figure 3 4: Stone Management Devices by Company (1 of 3) 63
Figure 3 5: Stone Management Devices by Company (2 of 3) 64
Figure 3 6: Stone Management Devices by Company (3 of 3) 65
Figure 3 7: BPH Treatments by Company 74
Figure 3 8: Erectile Dysfunction Devices by Company 77
Figure 3 9: Class 2 Device Recall Auriga Laser System 78
Figure 3 10: Class 2 Device Recall Fiber Strippers and Cleavers 79
Figure 3 11: Class 2 Device Recall StarMedTec LightTrail Reusable Fibers 80
Figure 3 12: Class 2 Device Recall Malecot Catheter Set 80
Figure 3 13: Class 2 Device Recall Encore(TM) 26 Inflation Device 80
Figure 3 14: Class 2 Device Recall Bardex Lubricath 3Way 75cc Continuous Irrigation Foley Catheter 81
Figure 3 15: Class 2 Device Recall Intermittent Catheters 81
Figure 3 16: Class 2 Device Recall leg bag 81
Figure 3 17: Class 2 Device Recall SURESTEP 82
Figure 3 18: Class 2 Device Recall PureWick External Catheter 82
Figure 3 19: Class 2 Device Recall SURESTEP Tray, BARDEX I.C. COMPLETE CARE, Urine Meter, Temperature STATLOCK Stabilization Device 82
Figure 3 20: Class 2 Device Recall BARD Irrigation Syringe, Rx Only, Sterile 83
Figure 3 21: Class 2 Device Recall Magic3 83
Figure 3 22: Class 2 Device Recall Optionvm Urinary Catheter. Male use only. Latex Free. Sterile, Rx only. 83
Figure 3 23: Class 3 Device Recall SureStep Tray, with AddaFoley 84
Figure 3 24: Class 2 Device Recall BARDEX 84
Figure 3 25: Class 3 Device Recall BARD Toomey Irrigation Syringe 70cc 84
Figure 3 26: Class 3 Device Recall Antibacterial Hydro Personal Catheter 84
Figure 3 27: Class 2 Device Recall Magic3 Intermittent Catheter with Sure Grip Hydrophilic Coated Silicone Coude tip 85
Figure 3 28: Class 2 Device Recall Magic3 Hydrophiliccoated Female Intermittent Catheter 85
Figure 3 29: Class 2 Device Recall Bard 100 LatexFree Urinary Drainage Bag with AntiReflux Chamber and Bard EXLok Sampling 85
Figure 3 30: Class 2 Device Recall Bard Dimension Stone Basket 86
Figure 3 31: Class 2 Device Recall CMax 86
Figure 3 32: Class 2 Device Recall Bard BrachySource Seed Implants 86
Figure 3 33: Class 2 Device Recall I125 CE Marked QuickLink Cartridges 87
Figure 3 34: Class 2 Device Recall Bard 87
Figure 3 35: Class 2 Device Recall XForce Nephrostomy Balloon Dilation Catheter Kit with Inflation Device 88
Figure 3 36: Class 2 Device Recall SelfCath Pediatric Catheter 89
Figure 3 37: Class 2 Device Recall Coloplast Conveen Urine Collection Leg Bag 89
Figure 3 38: Class 2 Device Recall Genesis Malleable Penile Prosthesis 89
Figure 3 39: Class 2 Device Recall StoneBreaker 90
Figure 3 40: Class 2 Device Recall OptiLite MultiUse Holmium Laser Fibers 90
Figure 3 41: Class 2 Device Recall Cook MultiUse Holmium Laser Fibers 91
Figure 3 42: Class 2 Device Recall Cook Bush 91
Figure 3 43: Class 2 Device Recall Aprima" Access Nonvascular Introducer Set 91
Figure 3 44: Class 2 Device Recall Ascend AQ 92
Figure 3 45: Class 2 Device Recall Oncentra Brachy 4.5 93
Figure 3 46: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 93
Figure 3 47: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 93
Figure 3 48: Class 2 Device Recall Oncentra Brachy treatment planning system 93
Figure 3 49: Class 2 Device Recall STORZ High Flow Insufflation Tubing (with filter) 94
Figure 3 50: Class 2 Device Recall Image1 SPIES XLINK Camera Control Unit (CCU) 94
Figure 3 51: Class 2 Device Recall Ureteroreno Videoscope & Fiberscope 95
Figure 3 52: Class 2 Device Recall A20975A: Working insert, with ramp, one way; A20976A: Bridge, one way; A20977A; Bridge, two way 95
Figure 3 53: Class 2 Device Recall Olympus High Frequency Resection Electrodes 95
Figure 3 54: Class 2 Device Recall Ureteroreno videoscope URFV2 and URFV2R 96
Figure 3 55: Class 2 Device Recall HF Cable WA00014A 96
Figure 3 56: Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx) 97
Figure 3 57: Mid-Urethral Sling Tensioning Trial (MUST) 97
Figure 3 58: Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence 98
Figure 3 59: Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) (SOAP) 98
Figure 3 60: LithoVue Single Use Disposable Ureteroscope 99
Figure 3 61: Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope 99
Figure 3 62: Indwelling Stent Discoloration Project 100
Figure 3 63: Reduction of Stent Associated Morbidity by Minimizing Stent Material. 100
Figure 3 64: PROPPER Prospective Registry of Outcomes With Penile Prosthesis (PROPPER) 101
Figure 3 65: Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor 102
Figure 3 66: Foley Catheter vs a Self-contained Valved Urinary Catheter 102
Figure 3 67: Bladder Morphology Using 2 Different Catheter Designs 103
Figure 3 68: Outpatient Labor Induction With the Transcervical Foley Balloon 103
Figure 3 69: Medical and Economic Evaluation for Intermediate-risk Prostate Cancer (GETUGP05) 104
Figure 3 70: Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy 104
Figure 3 71: Product Evaluation of a Newly Developed Intermittent Catheter. 105
Figure 3 72: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers 105
Figure 3 73: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheters in Healthy Volunteers 105
Figure 3 74: Virtue® European Study 106
Figure 3 75: Exploratory Study Investigating Urodynamic Parameters During Catheterisation 106
Figure 3 76: Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence 106
Figure 3 77: The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence (EASY) 107
Figure 3 78: Do Hydrophilic Catheters Decrease Pain and Discomfort of a Patient During Urodynamic Study (HYDRUDS) 107
Figure 3 79: Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients (ESCALE) 107
Figure 3 80: Ureteral Stent Study 108
Figure 3 81: Impact Ureteral Sheath Design During Ureteroscopy 108
Figure 3 82: Optimization of Ureterolysis During Hysterectomy 109
Figure 3 83: Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure 109
Figure 3 84: Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy 110
Figure 3 85: Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy 110
Figure 3 86: Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer (SINFRA_PROST) 111
Figure 3 87: Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy (BRAPROST) 111
Figure 3 88: Combined Treatment for Mixed Incontinence (ESTEEM) 112
Figure 3 89: TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings 112
Figure 3 90: Trans-obturator Mid-urethral Sling and the Single-incision Sling in Women With Stress Urinary Incontinence 113
Figure 3 91: Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy 114
Figure 3 92: Low-Intensity Extracorporeal Shockwave Therapy and Vacuum Erectile Device as a Treatment for Peyronies Disease 114
Figure 3 93: Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients. 115
Figure 3 94: Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease 115
Figure 3 95: Narrow Versus Wide Focal Zones for Shock Wave Lithotripsy of Renal Calculi 115
Figure 3 96: Are the Stone Density and Location Useful Parameters for Small Kidney Stones? 116
Figure 3 97: Durability of Flexible Ureteroscopes and Causes of Infection During Flexible Ureterorenoscopy 116
Figure 3 98: Comparison of Different Energy Sources During TUR-P 116
Figure 3 99: Effects of Flexible Ureteroscopy on Renal Blood Flow 117
Figure 3 100: A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting 117
Figure 3 101: Blue Light Cystoscopy With Cysview® Registry (BLCCR) 117
Figure 3 102: Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors 118
Figure 3 103: Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes 118
Figure 3 104: T-DOC® 5 Fr Pediatric Clinical Investigation 119
Figure 3 105: Air vs Water Catheters (AvW (Bonn)) 119
Figure 3 106: A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use 120
Figure 3 107: Portable Pves Study 120
Figure 3 108: Ambulatory Pessary Trial 120
Figure 3 109: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters 121
Figure 3 110: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Silver vs Silver Coated Foley Catheters 121
Figure 3 111: Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery 122
Figure 3 112: Quality of Life in Kidney Stone Patients Undergoing Surgery 122
Figure 3 113: Prostate Vaporization Techniques in Canadian Hospital 123
Figure 3 114: Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode 123
Figure 3 115: Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy 124
Figure 3 116: Results of Safety Guidewire Use in Ureteroscopic Stone Surgery 124
Figure 3 117: Transurethral En Bloc Versus Standard Resection of Bladder Tumour 124
Figure 3 118: PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors (PK Button) 125
Figure 4 1: Currency Exchange Rate, 2019 127
Figure 4 2: Urological Device Market by Segment, Brazil, 2016 – 2026 (US$M) 129
Figure 4 3: Urological Device Market by Segment, Brazil, 2016 – 2026 (R$M) 130
Figure 4 4: Urological Device Market Growth by Segment, 2016 – 2026 136
Figure 4 5: Drivers and Limiters, Urological Device Market, Brazil, 2019 140
Figure 4 6: Leading Competitors, Urological Device Market, Brazil, 2019 146
Figure 4 7: SWOT Analysis, Boston Scientific (1 of 2) 162
Figure 4 8: SWOT Analysis, Boston Scientific (2 of 2) 163
Figure 4 9: SWOT Analysis, C. R. Bard (Becton Dickinson) (1 of 2) 164
Figure 4 10: SWOT Analysis, C. R. Bard (Becton Dickinson) (2 of 2) 165
Figure 4 11: SWOT Analysis, Coloplast 166
Figure 4 12: SWOT Analysis, Cook Medical (1 of 2) 167
Figure 4 13: SWOT Analysis, Cook Medical (2 of 2) 168
Figure 4 14: SWOT Analysis, Ethicon (Johnson & Johnson) 169
Figure 4 15: SWOT Analysis, Karl Storz 170
Figure 4 16: SWOT Analysis, Laborie 171
Figure 4 17: SWOT Analysis, Olympus (1 of 2) 172
Figure 4 18: SWOT Analysis, Olympus (2 of 2) 173
Figure 5 1: Urological Procedures by Type, Brazil, 2016 – 2026 175
Figure 5 2: Urinary Incontinence Procedures by Type, Brazil, 2016 – 2026 179
Figure 5 3: Male Incontinence Management Procedures by Type, Brazil, 2016 – 2026 182
Figure 5 4: Female Incontinence Management Procedures by Type, Brazil, 2016 – 2026 185
Figure 5 5: Pelvic Organ Prolapse Repair Procedures by Type, Brazil, 2016 – 2026 187
Figure 5 6: Stone Management Procedures by Type, Brazil, 2016 – 2026 189
Figure 5 7: ESWL Procedures, Brazil, 2016 – 2026 191
Figure 5 8: Transurethral Procedures by Type, Brazil, 2016 – 2026 193
Figure 5 9: Ureteral Stent Placement Procedures, Brazil, 2016 – 2026 195
Figure 5 10: PCNL Procedures, Brazil, 2016 – 2026 197
Figure 5 11: BPH Procedures by Type, Brazil, 2016 – 2026 199
Figure 5 12: Erectile Dysfunction Management Procedures by Type, Brazil, 2016 – 2026 202
Figure 6 1: Urinary Incontinence Device Management Market by Segment, Brazil, 2016 – 2026 (US$M) 206
Figure 6 2: Urinary Incontinence Device Management Market by Segment, Brazil, 2016 – 2026 (R$M) 207
Figure 6 3: Urinary Catheter Market by Segment, Brazil, 2016 – 2026 (US$M) 212
Figure 6 4: Urinary Catheter Market by Segment, Brazil, 2016 – 2026 (R$M) 212
Figure 6 5: Intermittent Catheter Market, Brazil, 2016 – 2026 214
Figure 6 6: Foley Catheter Market, Brazil, 2016 – 2026 216
Figure 6 7: Male External Catheter Market, Brazil, 2016 – 2026 218
Figure 6 8: Urethral Bulking Agent Market by Segment, Brazil, 2016 – 2026 (US$M) 220
Figure 6 9: Urethral Bulking Agent Market by Segment, Brazil, 2016 – 2026 (R$M) 221
Figure 6 10: Total Urethral Bulking Agent Market, Brazil, 2016 – 2026 222
Figure 6 11: Male Urethral Bulking Agent Market, Brazil, 2016 – 2026 224
Figure 6 12: Female Urethral Bulking Agent Market, Brazil, 2016 – 2026 226
Figure 6 13: Incontinence Management Device Market by Segment, Brazil, 2016 – 2026 (US$M) 229
Figure 6 14: Incontinence Management Device Market by Segment, Brazil, 2016 – 2026 (R$M) 229
Figure 6 15: Male Implantable Incontinence Device Market by Segment, U.S., 2016 – 2026 (US$M) 232
Figure 6 16: Male Implantable Incontinence Device Market by Segment, U.S., 2016 – 2026 (R$M) 232
Figure 6 17: Total Male Implantable Incontinence Device Market, Brazil, 2016 – 2026 234
Figure 6 18: Male Incontinence Sling Market, Brazil, 2016 – 2026 236
Figure 6 19: Male Artificial Urinary Sphincter Market, Brazil, 2016 – 2026 238
Figure 6 20: Female Incontinence Sling Market by Type, Brazil, 2016 – 2026 (US$M) 241
Figure 6 21: Female Incontinence Sling Market by Type, Brazil, 2016 – 2026 (R$M) 241
Figure 6 22: Total Female Incontinence Sling Market, Brazil, 2016 – 2026 243
Figure 6 23: Transvaginal Tape Female Incontinence Sling Market, Brazil, 2016 – 2026 245
Figure 6 24: Transobturator Female Incontinence Sling Market, Brazil, 2016 – 2026 247
Figure 6 25: Single-Incision Female Incontinence Sling Market, Brazil, 2016 – 2026 249
Figure 6 26: Drivers and Limiters, Urinary Incontinence Management Device Market, Brazil, 2019 254
Figure 6 27: Leading Competitors, Urinary Incontinence Management Device Market, Brazil, 2019 258
Figure 7 1: Pelvic Organ Prolapse Repair Device Market by Segment, Brazil, 2016 – 2026 (US$M) 263
Figure 7 2: Pelvic Organ Prolapse Repair Device Market by Segment, Brazil, 2016 – 2026 (R$M) 263
Figure 7 3: Total Pelvic Organ Prolapse Repair Device Market, Brazil, 2016 – 2026 268
Figure 7 4: Transvaginal Mesh Market, Brazil, 2016 – 2026 271
Figure 7 5: Sacrocolpopexy Mesh Market, Brazil, 2016 – 2026 273
Figure 7 6: Drivers and Limiters, Pelvic Organ Prolapse Repair Device Market, Brazil, 2019 277
Figure 7 7: Leading Competitors, Pelvic Organ Prolapse Repair Market, Brazil, 2019 279
Figure 8 1: Stone Management Device Market by Segment, Brazil, 2016 – 2026 (US$M) 284
Figure 8 2: Stone Management Device Market by Segment, Brazil, 2016 – 2026 (R$M) 285
Figure 8 3: ESWL Equipment Market, Brazil, 2016 – 2026 290
Figure 8 4: ISWL Equipment Market, U.S., 2016 – 2026 293
Figure 8 5: Holmium Laser Market by Segment, Brazil, 2016 – 2026 (US$M) 295
Figure 8 6: Holmium Laser Market by Segment, Brazil, 2016 – 2026 (R$M) 296
Figure 8 7: Holmium Laser Equipment Market, Brazil, 2016 – 2026 298
Figure 8 8: Holmium Laser Fiber Market, Brazil, 2016 – 2026 301
Figure 8 9: Stone Fragment Retrieval Device Market by Segment, Brazil, 2016 – 2026 (US$M) 304
Figure 8 10: Stone Fragment Retrieval Device Market by Segment, Brazil, 2016 – 2026 (R$M) 305
Figure 8 11: Total Stone Fragment Retrieval Device Market, Brazil, 2016 – 2026 307
Figure 8 12: Nitinol Stone Fragment Retrieval Device Market, Brazil, 2016 – 2026 309
Figure 8 13: Stainless Steel Stone Fragment Retrieval Device Market, Brazil, 2016 – 2026 311
Figure 8 14: Ureteral Stent Market, Brazil, 2016 – 2026 314
Figure 8 15: Ureteral Guidewire Market, Brazil, 2016 – 2026 317
Figure 8 16: Drivers and Limiters, Stone Management Device Market, Brazil, 2019 322
Figure 8 17: Leading Competitors, Stone Management Device Market, Brazil, 2019 327
Figure 9 1: BPH Treatment Device Market by Segment, U.S., 2016 – 2026 (US$M) 335
Figure 9 2: BPH Treatment Device Market by Segment, U.S., 2016 – 2026 (R$M) 335
Figure 9 3: TURP Market by Segment, Brazil, 2016 – 2026 (US$M) 340
Figure 9 4: TURP Market by Segment, Brazil, 2016 – 2026 (R$M) 340
Figure 9 5: Monopolar Electrode Market, Brazil, 2016 – 2026 342
Figure 9 6: Bipolar Electrode Market, U.S., 2016 – 2026 344
Figure 9 7: Laser BPH Market by Segment, Brazil, 2016 – 2026 (US$M) 347
Figure 9 8: Laser BPH Market by Segment, Brazil, 2016 – 2026 (R$M) 347
Figure 9 9: Laser BPH Equipment Market, Brazil, 2016 – 2026 349
Figure 9 10: Laser BPH Fiber Market, Brazil, 2016 – 2026 351
Figure 9 11: Drivers and Limiters, BPH Treatment Device Market, Brazil, 2019 357
Figure 9 12: Leading Competitors, BPH Treatment Device Market, Brazil, 2019 360
Figure 10 1: Erectile Dysfunction Device Market by Segment, Brazil, 2016 – 2026 (US$M) 365
Figure 10 2: Erectile Dysfunction Device Market by Segment, Brazil, 2016 – 2026 (R$M) 366
Figure 10 3: Inflatable Erectile Dysfunction Device Market, Brazil, 2016 – 2026 371
Figure 10 4: Malleable Erectile Dysfunction Device Market, Brazil, 2016 – 2026 373
Figure 10 5: Drivers and Limiters, Erectile Dysfunction Device Market, Brazil, 2019 377
Figure 10 6: Leading Competitors, Erectile Dysfunction Device Market, Brazil, 2019 380

Companies
• Allium Medical • Lumenis
• Amecath • Medconi
• Americanas • Medfibers
• AMS • MedGyn
• Amsino • Medi-Globe
• BARD • MedNova
• Biolitec • MedPro Medical
• Biosat • Olympus
• Boston Scientific • OmniGuide
• Cardinal Health • OrtoPonto
• Coloplast • Peco Medical
• ConvaTec • Plasti-Med
• Cook Medical • PNN Medical
• Deroyal • Promedon
• Dipher • Prosurg, Inc.
• Direx Group • Richard Wolf
• Dornier MedTech • Rocamed
• Electro Medical Systems • Siemens
• Ethicon • Silimed
• Fibra Cirurgica • Simbionix Ltd.
• Gigaa Laser • Smiths Medical
• Handle • Teleflex
• Hollister • Trimedyne
• HR Penile Prosthesis • UroMed
• Jena Surgical • UroVision
• Karl Storz • Vitae Saude
• LABORIE • ZSI

$8,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

[email protected]
+1 212 564 2838

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

[email protected]
+1 212 564 2838

Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838